These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11174127)

  • 1. [Standards, Options and Recommendations (SOR) on hormone therapy in nonmetastatic cancer of the breast]].
    Vennin P
    Bull Cancer; 2000 Dec; 87(12):948-50. PubMed ID: 11174127
    [No Abstract]   [Full Text] [Related]  

  • 2. [Standards, Options and Recommendations for non metastatic breast cancer patients].
    Mauriac L
    Bull Cancer; 2002 Feb; 89(2):207-24. PubMed ID: 11888860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical practice guidelines: Standards, Options and Recommendations for first line medical treatment of patients with ovarian neoplasms (summary report)].
    Lhommé C; Ray-Coquard I; Guastalla JP; Bataillard A; Thomas L; Bonnier P; Dargent D; Dohollou N; Ganem G; Lefranc JP; Misset JL; Rixe O; Tchiknavorian X; Tournigand C; Villet R; Bachelot T; Kerbrat P; Fervers B; Basuyau JP; Cohen-Solal-Le Nir C; Morice P; Duvillard P; Voog E; ; ; ; ; ;
    Bull Cancer; 2004; 91(7-8):609-20. PubMed ID: 15381451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).
    Levine M;
    CMAJ; 2001 Jan; 164(2):213. PubMed ID: 11332317
    [No Abstract]   [Full Text] [Related]  

  • 5. Update: NCCN breast cancer Clinical Practice Guidelines.
    Carlson RW; McCormick B
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S7-11. PubMed ID: 16280118
    [No Abstract]   [Full Text] [Related]  

  • 6. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
    Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
    Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical practice guideline for breast cancer].
    Takatsuka Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():175-81. PubMed ID: 17682154
    [No Abstract]   [Full Text] [Related]  

  • 8. [Early-stage breast cancer - strategies for adjuvant systemic therapy].
    Görner M; Just M; Gerull S
    Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):230-8. PubMed ID: 18716990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Landmark trials in endocrine adjuvant therapy for breast carcinoma.
    Gradishar W
    Cancer; 2006 Mar; 106(5):975-81. PubMed ID: 16435388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations.
    Thuerlimann B; Koeberle D; Senn HJ
    Eur J Cancer; 2007 Jan; 43(1):46-52. PubMed ID: 17085045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment recommendations in older women with breast cancer: a survey of oncologists.
    Hurria A; Naeim A; Elkin E; Limaye S; Grover A; Hudis C; Pearce C; Robson M
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):255-60. PubMed ID: 17098441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of breast cancer: recommendations and rationale.
    Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
    [No Abstract]   [Full Text] [Related]  

  • 17. The evolving role of endocrine therapy for treatment and prevention of breast cancer.
    Gradishar WJ; Jordan VC
    Cancer Chemother Biol Response Modif; 2001; 19():215-36. PubMed ID: 11686016
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy].
    Ychou M; Gory-Delabaere G; Blanc P; Bosquet L; Duffour J; Giovannini M; Guillemin F; Lemanski C; Marchal F; Masson B; Merrouche Y; Monges G; Adenis A; Bosset JF; Bouché O; Conroy T; Pezet D; Triboulet JP; ; ;
    Cancer Radiother; 2004 Oct; 8(5):322-35. PubMed ID: 15561598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Additional effect of SERM: mammary gland].
    Kurebayashi J
    Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards optimal endocrine therapy for hormone-sensitive breast cancer: initial versus sequential adjuvant aromatase inhibition.
    Spicer J; Ellis P
    Cancer Lett; 2007 Apr; 248(2):165-74. PubMed ID: 16919870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.